Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1023 of 1,261
  1. US 7589100

    Non-hygroscopic and powdery amorphous pimecrolimus

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  2. US 7588703

    Microencapsulation system and method

    United States of America as represented by the Administrator of NASA · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  3. US 7588912

    Compositions and methods for preventing and treating anthrax diseases

    The Regents of the University of California · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  4. US 7589157

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  5. US 7589181

    Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  6. US 7589200

    5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  7. US 7589220

    Inhibitors of the anandamide transporter

    UNIVERSITY OF CONNECTICUT · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  8. US 7589214

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  9. US 7585520

    Compositions containing both sedative and non-sedative antihistamines and sleep aids

    Collegium Pharmaceutical, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  10. US 7585844

    Myosin light chain kinase inhibitors and methods of use

    University College Cardiff Consultants Limited · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  11. US 7585842

    Human kunitz-type inhibitor with enhanced antifibrinolytic activity

    The Regents of the University of California · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  12. US 7585883

    Substituted pyridines and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  13. US 7585880

    Phenylpropanoic acid derivatives

    Takeda Pharmaceutical Company Limited · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  14. US 7585879

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  15. US 7585667

    Negative strand RNA virus replicon

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  16. US 7585653

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Theravance, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  17. US 7585841

    Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  18. US 7585622

    Increasing the proliferative capacity of cells using telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  19. US 7585877

    Aminophenyl derivatives as selective androgen receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  20. US 7585852

    Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation

    Solidago AG · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  21. US 7585868

    Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

    The Regents of the University of California · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  22. US 7582430

    Immunoliposome-nucleic acid amplification (ILNAA) assay

    The United States of America as represented by the Secretary of the Army · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  23. US 7582307

    Dermatological composition

    Harmony Labs, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  24. US 7582442

    Methods and compositions for using aleveolar macrophage phospholipase A2

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.